CARDINAL HEALTH SEY54CPCANRecalls & reported problems

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10887488555294), received between May 30, 2018 and May 30, 2018 — classified as 2 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

• InjuryMay 30, 2018Insufficient Device Problem Information

  THE CUSTOMER STATED THAT ONE OF THEIR PATIENTS DEVELOPED A RASH TO THE EYES AND SURROUNDING AREA FOLLOWING AN OPHTHALMIC SURGERY. THE COMPONENT SOURCE WAS UNKNOWN BUT THE CUSTOMER FELT IT COULD POSSIBLY BE FROM THE TRANSPARENT DRESSING TD-24CNS2 FROM THE BASIC CATARACT PACK/ SEY54CPCAN. THE PATIENT WAS TREATED WITH PREDNISOLONE ACETATE 1% 1GTT BOTH EYES, TOPICAL BACITRACIN/POLYSPORIN AND TOPICAL HYDROCORTISONE 1% ON SURROUNDING AREA AND ORAL CEPHALEXIN. THE RASH RESOLVED.

  Patient problems: Rash

  MAUDE report 7554853 ↗
• InjuryMay 30, 2018Insufficient Device Problem Information

  THE CUSTOMER STATED THAT ONE OF THEIR PATIENTS DEVELOPED A RASH TO THE LOWER LID AND CHEEK FOLLOWING AN OPHTHALMIC SURGERY. THE COMPONENT SOURCE WAS UNKNOWN, BUT THE CUSTOMER FELT IT COULD POSSIBLY BE FROM THE TRANSPARENT DRESSING TD-24CNS2 FROM THE BASIC CATARACT PACK/ SEY54CPCAN. THE PATIENT WAS TREATED WITH TOBRADEX OINTMENT AND RASH RESOLVED.

  Patient problems: Rash

  MAUDE report 7554762 ↗